Unit University of Macau
Faculty/Department Institute of Chinese Medical Sciences – Department of Pharmaceutical Affairs
Signature Research Cluster Macao Studies from a Global Perspective
Research Interest
  • Regulatory science in medical and pharmaceutical products
  • Evidence base about traditional, complementary and integrative medicine
  • Community health and chronic disease management
  • Social and administrative pharmacy

Signature Publications

  • Yao D, Hu H, Ung COL. The development and prospect of drug and medical device regulation in Macao Special Administration Region. China Food & Drug Administration Magazine. 2021(12):16-25. (Chinese)姚東寧,胡豪,吳靄琳.澳門特別行政區藥品及醫療器械監管的發展與展望[J].中國食品藥品監管,2021(12):16-25.
  • Li M, Chen S, Lai Y, Liang Z, Wang J, Shi J, Lin H, Yao D, Hu H, Ung COL. Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model. Front Med (Lausanne). 2021 May 31;8:669509. doi: 10.3389/fmed.2021.669509. PMID: 34136505; PMCID: PMC8200400.
  • Liang Z, Lai Y, Li M, Shi J, Lei CI, Hu H, Ung COL. Applying regulatory science in traditional Chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications. Chin Med. 2021 Feb 16;16(1):23. doi: 10.1186/s13020-021-00433-2. PMID: 33593397; PMCID: PMC7884970.